Finance

Lists
600993:SHA
Mayinglong Pharmaceutical Group Co Ltd
CNÂ¥23.07
+0.04%
(+0.010) 1D
Sep 7, 9:31:59 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600993...
Open
CNÂ¥23.06
High
CNÂ¥23.18
Low
CNÂ¥23.01
Mkt. cap
9.94B
Avg. vol.
5.36M
Volume
112.20K
Dividend
3.03%
Quarterly dividend
CNÂ¥0.17
Ex-dividend date
Aug 5, 2026
P/E ratio
16.55
52-wk high
CNÂ¥30.18
52-wk low
CNÂ¥21.22
EPS
CNÂ¥1.39
Shares outstanding
431.05M
No. of employees
3K
Open
CNÂ¥23.06
High
CNÂ¥23.18
Low
CNÂ¥23.01
Mkt. cap
9.94B
Avg. vol.
5.36M
Volume
112.20K
Dividend
3.03%
Quarterly dividend
CNÂ¥0.17
Ex-dividend date
Aug 5, 2026
P/E ratio
16.55
52-wk high
CNÂ¥30.18
52-wk low
CNÂ¥21.22
EPS
CNÂ¥1.39
Shares outstanding
431.05M
No. of employees
3K
About Mayinglong Pharmaceutical Group Co Ltd
CEO-
Employees2.54K
Founded1582
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
888.26M
1.03B
1.01B
999.38M
Cost of goods sold
460.66M
521.28M
524.38M
544.42M
Cost of revenue
460.66M
521.28M
524.38M
544.42M
Research and development expenses
20.83M
19.99M
17.06M
14.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
232.34M
392.42M
219.69M
256.36M
Operating expense
252.95M
423.97M
243.25M
270.99M
Total operating expenses
713.61M
945.24M
767.64M
815.41M
Operating income
174.65M
84.08M
244.73M
183.97M
Other non operating income
6.84M
2.12M
-100.17K
-6.63M
EBT including unusual items
187.83M
100.89M
255.42M
187.60M
EBT excluding unusual items
200.49M
110.29M
253.57M
177.87M
Income tax expense
25.95M
14.42M
36.14M
29.69M
Effective tax rate
13.81%
14.30%
14.15%
15.83%
Other operating expenses
-8.32M
20.94M
4.28M
2.18M
Net income
157.79M
80.48M
212.59M
150.03M
Net profit margin
17.76%
7.82%
21.00%
15.01%
Earnings per share
-
-
-
-
Interest and investment income
20.70M
26.15M
10.03M
1.10M
Interest expense
-1.72M
-2.19M
-1.10M
-560.32K
Net interest expenses
18.99M
23.96M
8.94M
536.07K
Depreciation and amortization charges
-
-
-
-
EBITDA
185.56M
98.76M
259.41M
199.11M
Gain or loss from assets sale
-216.81K
89.70K
-
25.55K
AI content may include mistakes. Learn more
Google apps